PetIQ (PETQ)
(Delayed Data from NSDQ)
$18.44 USD
-0.25 (-1.34%)
Updated May 10, 2024 04:00 PM ET
After-Market: $18.44 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth B Momentum C VGM
Price, Consensus and EPS Surprise
PETQ 18.44 -0.25(-1.34%)
Will PETQ be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for PETQ based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for PETQ
PetIQ (PETQ) Gears Up to Report Q1 Earnings: What's in Store?
Baxter International (BAX) Q1 Earnings and Revenues Surpass Estimates
PETQ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is PetIQ (PETQ) a Great Value Stock Right Now?
Wall Street Analysts Think PetIQ (PETQ) Could Surge 76.18%: Read This Before Placing a Bet
PetIQ, Inc. (PETQ) Is a Trending Stock: Facts to Know Before Betting on It
Other News for PETQ
PetIQ, Inc. (PETQ) Q1 2024 Earnings Call Transcript
PetIQ, Inc. 2024 Q1 - Results - Earnings Call Presentation
PetIQ Inc (PETQ) Surpasses Q1 Revenue and Earnings Expectations, Raises 2024 Outlook
Analysts Are Bullish on These Healthcare Stocks: Coherus Biosciences (CHRS), Petiq (PETQ)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Petiq (PETQ), Leafly Holdings, Inc. (LFLY) and AMN Healthcare Services (AMN)